Skip to main content

ADHD Meds Initiation Linked to Lower Rate of All-Cause Mortality

Medically reviewed by Carmen Pope, BPharm. Last updated on March 12, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, March 12, 2024 -- For individuals diagnosed with attention-deficit/hyperactivity disorder (ADHD), medication initiation is associated with a significantly lower rate of all-cause mortality and unnatural-cause mortality, according to a study published in the March 12 issue of the Journal of the American Medical Association.

Lan Li, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined whether initiation of ADHD pharmacotherapy was associated with reduced mortality risk among individuals with ADHD in an observational nationwide cohort study conducted in Sweden. Individuals aged 6 through 64 years with an incident diagnosis of ADHD from 2007 through 2018 and no ADHD medication dispensation before diagnosis were identified; 56.7 percent of the 148,578 individuals with ADHD initiated ADHD medication.

The researchers found that the two-year mortality risk was lower in the initiation treatment strategy group than the non-initiation treatment strategy group (39.1 versus 48.1 per 10,000 individuals). Significantly lower rates of all-cause mortality and unnatural-cause mortality were observed in association with ADHD medication initiation (hazard ratio, 0.79 and 0.75, respectively); no significant difference was seen in natural-cause mortality.

"ADHD medication may reduce the risk of unnatural-cause mortality by alleviating the core symptoms of ADHD and its psychiatric comorbidities, leading to improved impulse control and decision-making, ultimately reducing the occurrence of fatal events," the authors write.

One author disclosed ties to Shire/Takeda, Evolan, and Medici.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

One in Nine U.S. Children Have Ever Been Diagnosed With ADHD

THURSDAY, May 23, 2024 -- Diagnoses of attention-deficit/hyperactivity disorder (ADHD) in U.S. children continue to increase, with approximately one in nine having ever received a...

Prenatal Opioid Exposure Not Tied to Neuropsychiatric Disorders in Offspring

THURSDAY, April 25, 2024 -- Prenatal opioid exposure seems not to be associated with a meaningful increase in the risk for neuropsychiatric disorders in offspring, according to a...

Green Space May Benefit Mental Health in Early Childhood

WEDNESDAY, April 17, 2024 -- Green space is associated with fewer internalizing symptoms in early childhood, according to a study published online April 10 in JAMA Network...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.